Founded in 2011, Chewy is a leading e-commerce retailer of pet food, toys, supplies, and medications in North America... Show more
Chewy, Inc. shares have been trading in a relatively narrow range in recent weeks, reflecting a stock that has recovered from its lows but remains well below prior peaks. As of the most recent completed session in early September 2026, CHWY closed near $23.66, giving the company a market capitalization of roughly $9.7 billion. Over the trailing month, the stock has been essentially flat, down about 1.5%, while the three-month view shows a more constructive rebound of approximately 14.6%.
The longer-term picture remains challenging. Chewy is down roughly 28% year to date and about 42% over the past 12 months, with a 52-week range spanning $17.40 to $43.50. This wide spread highlights both the stock's volatility and the market's ongoing reassessment of growth expectations in the pet retail category.
Chewy is a leading online retailer of pet food, supplies, medications, and related services. Through its websites and mobile apps, the company offers approximately 190,000 products and service offerings, partnering with roughly 4,000 brands while also developing its own private-label lines. Its core differentiator is the Autoship subscription program, which automates recurring deliveries of food, litter, and medication and generates a highly predictable revenue stream.
Beyond retail, Chewy has expanded into pet healthcare through Chewy Health, pharmacy services, and a growing network of Chewy Vet Care clinics. The company competes against broad e-commerce and retail players such as Amazon (AMZN), Walmart (WMT), and Petco (WOOF), as well as specialty pet retailers. Investors follow Chewy closely because of its recurring Autoship base, customer loyalty, and the margin leverage that comes from scaling a highly automated fulfillment network.
Chewy's first-quarter fiscal 2026 report, released in June 2026, set the tone for recent trading. Net sales increased 7.7% year over year to $3.36 billion, and active customers grew 3.6% to 21.5 million, with net sales per active customer reaching $597. Autoship customer sales rose 10.5% to $2.83 billion, now 84.4% of net sales. Gross margin expanded 50 basis points to 30.1%, and adjusted EBITDA climbed 31.3% to $253.1 million.
However, management lowered its fiscal 2026 net sales outlook to a range of $13.40 billion to $13.55 billion, down from a prior range of $13.60 billion to $13.75 billion, citing a more cautious consumer and softer premiumization trends. The company maintained its adjusted EBITDA margin guidance of 6.6% to 6.8%, signaling a willingness to protect profitability even as top-line expectations moderate.
Strategic activity has also shaped sentiment. Chewy completed the acquisition of SmartPak, strengthening its equine health offering, and closed its roughly $400 million acquisition of Modern Animal, a technology-forward veterinary platform that expands its clinic footprint. The company repurchased $200 million of stock during the quarter. Analyst actions have been mixed but generally constructive: Piper Sandler reiterated an Overweight rating with a $30 target, Mizuho maintained Outperform while lowering its target to $32 from $40, and TD Cowen reiterated Buy with a $34 target, while UBS held Neutral with a $24 target.
Tickeron's Trending AI Robots page highlights a curated selection of algorithmic trading bots that are currently generating notable performance. Tickeron offers hundreds of AI trading bots that trade thousands of tickers, but only the top-performing and most relevant bots appear in this featured section. Each bot operates with its own strategy, timeframe, and performance metrics, giving users a range of approaches to explore rather than a single one-size-fits-all signal. For traders and investors looking to complement their own research with data-driven automation, the Trending AI Robots page provides a useful starting point to review current leaders across the platform.
The most immediate catalyst for Chewy is its fiscal second-quarter 2026 earnings report, scheduled for September 9, 2026. Investors will be watching net sales growth, Autoship penetration, and any updates to full-year guidance, particularly given the softer consumer backdrop that management flagged in the first quarter. Net sales per active customer will be a closely scrutinized metric, as premiumization and product attach rates remain under pressure.
Longer-term, the expansion of Chewy Vet Care and the integration of Modern Animal represent a key growth vector, with management targeting roughly 60 clinics by the end of fiscal 2026. AI-driven efficiency initiatives are expected to contribute low tens of millions of dollars in savings during fiscal 2026 and more than $50 million in fiscal 2027. Sponsored Ads and private brands continue to support margins. Against these opportunities, investors should monitor macroeconomic conditions, competitive intensity, and whether consumer spending in the pet category stabilizes or deteriorates further.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CHWY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 27, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 39 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHWY as a result. In 66 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
CHWY moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHWY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CHWY's RSI Indicator exited the oversold zone, 26 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHWY advanced for three days, in 218 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
CHWY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 116 of 170 cases where CHWY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. CHWY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.148) is normal, around the industry mean (34.700). P/E Ratio (32.846) is within average values for comparable stocks, (39.840). CHWY's Projected Growth (PEG Ratio) (0.434) is slightly lower than the industry average of (1.016). Dividend Yield (0.000) settles around the average of (0.085) among similar stocks. P/S Ratio (0.686) is also within normal values, averaging (1.352).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHWY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which operates as a web-based, pet supplies e-tailer.
Industry InternetRetail